Warning against second-generation antiandrogen for metastatic castration sensitive prostate cancer. Inoue T, Sasaki T, Kato M, Masui S, et al. BJU Int 2021 Aug 1. doi: 10.1111/bju.15561.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Inoue T, Sasaki T, Kato M, Masui S, et al. Warning against second-generation antiandrogen for metastatic castration sensitive prostate cancer. BJU Int 2021 Aug 1. doi: 10.1111/bju.15561.
PMID: 34333840